1. Home
  2. OCS vs SIFY Comparison

OCS vs SIFY Comparison

Compare OCS & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • SIFY
  • Stock Information
  • Founded
  • OCS 2003
  • SIFY 1995
  • Country
  • OCS Switzerland
  • SIFY India
  • Employees
  • OCS N/A
  • SIFY N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • SIFY Computer Software: Programming Data Processing
  • Sector
  • OCS Health Care
  • SIFY Technology
  • Exchange
  • OCS Nasdaq
  • SIFY Nasdaq
  • Market Cap
  • OCS 956.4M
  • SIFY 844.3M
  • IPO Year
  • OCS N/A
  • SIFY 1999
  • Fundamental
  • Price
  • OCS $17.34
  • SIFY $12.04
  • Analyst Decision
  • OCS Strong Buy
  • SIFY
  • Analyst Count
  • OCS 4
  • SIFY 0
  • Target Price
  • OCS $35.75
  • SIFY N/A
  • AVG Volume (30 Days)
  • OCS 14.2K
  • SIFY 169.0K
  • Earning Date
  • OCS 11-06-2025
  • SIFY 10-21-2025
  • Dividend Yield
  • OCS N/A
  • SIFY N/A
  • EPS Growth
  • OCS N/A
  • SIFY N/A
  • EPS
  • OCS N/A
  • SIFY N/A
  • Revenue
  • OCS $960,668.00
  • SIFY $480,237,627.00
  • Revenue This Year
  • OCS $11.49
  • SIFY N/A
  • Revenue Next Year
  • OCS $1,784.02
  • SIFY $13.46
  • P/E Ratio
  • OCS N/A
  • SIFY N/A
  • Revenue Growth
  • OCS N/A
  • SIFY 12.82
  • 52 Week Low
  • OCS $11.78
  • SIFY $2.05
  • 52 Week High
  • OCS $23.08
  • SIFY $12.44
  • Technical
  • Relative Strength Index (RSI)
  • OCS 48.91
  • SIFY 78.38
  • Support Level
  • OCS $16.94
  • SIFY $11.25
  • Resistance Level
  • OCS $17.34
  • SIFY $12.44
  • Average True Range (ATR)
  • OCS 0.40
  • SIFY 0.73
  • MACD
  • OCS 0.08
  • SIFY 0.11
  • Stochastic Oscillator
  • OCS 73.35
  • SIFY 88.83

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

Share on Social Networks: